Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Klotho Neurosciences Inc (KLTO)

Klotho Neurosciences Inc (KLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 38,548
  • Shares Outstanding, K 73,537
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,150 K
  • EBIT $ -7 M
  • EBITDA $ -7 M
  • 60-Month Beta 9.08
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.68
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.32
  • Most Recent Earnings $-0.05 on 11/13/25
  • Next Earnings Date 03/30/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2100 +149.62%
on 02/13/26
0.7398 -29.14%
on 03/04/26
+0.2936 (+127.32%)
since 02/11/26
3-Month
0.2100 +149.62%
on 02/13/26
0.7398 -29.14%
on 03/04/26
+0.1000 (+23.57%)
since 12/11/25
52-Week
0.1135 +361.85%
on 04/04/25
3.9099 -86.59%
on 06/10/25
+0.2414 (+85.36%)
since 03/11/25

Most Recent Stories

More News
Klotho Neurosciences Completes Rebranding to Greenland Mines Ltd and Change of Nasdaq Ticker Symbol to GRML

Company to hold investor webcast on March 12, 2026 at 4:15PM ET to discuss its expanded focus on critical minerals development in Greenland

GRML : 0.4500 (-3.85%)
KLTO : 0.5242 (+0.81%)
KLOTHO NEUROSCIENCES ACQUIRES GREENLAND MINES CORP., SECURING CONTROL OF A $68 BILLION PALLADIUM, GOLD, PLATINUM, AND CRITICAL MINERAL DEPOSIT IN THE WORLD'S MOST STRATEGICALLY VITAL EMERGING TRADE CORRIDOR

Transaction delivers shareholders direct ownership in one of the largest undeveloped palladium-gold deposits on Earth, establishing a new western champion in critical mineral supply security; Company to...

KLTO : 0.5242 (+0.81%)
Klotho Neurosciences (NASDAQ:KLTO) Initiates Development of the "Klotho Clock," a Diagnostic Biological Aging and Longevity Clock that Unlocks Health Testing Through Epigenetics and Artificial Intelligence (AI)

The Company enlists industry veteran Dr. Bret Barnes to oversee the development of new diagnostic offerings

KLTO : 0.5242 (+0.81%)
Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein ("s-KL") Isoform of the Human Klotho Gene Sequence

NEW YORK , Feb. 18, 2026 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO) ("Klotho" or the Company) announces the acceptance of 18 claims within a patent application filed in Australia for...

KLTO : 0.5242 (+0.81%)
Beyond Weight Loss: The "Cellular Reset" That Could Create the Next Biotech Supercycle

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – The longevity economy is entering a massive repricing event as researchers confirm that metabolic dysfunction...

LGVN : 0.8200 (+1.36%)
AVAI : 0.3625 (-4.61%)
BIOA : 19.73 (-0.78%)
GAA : 33.82 (-1.00%)
DNLI : 20.70 (-4.21%)
MAPT : 0.0001 (-50.00%)
KLTO : 0.5242 (+0.81%)
Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award

NEW YORK , Nov. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO ) (the "Company" or "Klotho"), a U.S.-based biogenetics company, announces it has been selected as winner of the Fifth...

KLTO : 0.5242 (+0.81%)
Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston

NEW YORK , Oct. 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") a U.S.-based biogenetics company, announces that members of its leadership team will...

KLTO : 0.5242 (+0.81%)
Klotho Neurosciences Announces Expiration of Letter of Intent

NEW YORK , Oct. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") today announced that its Letter of Intent with Turn Biotechnologies was allowed to expire...

KLTO : 0.5242 (+0.81%)
Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership

NEW YORK and PALO ALTO, Calif. , Sept. 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho" or "the Company") today announced it has signed a Letter of...

KLTO : 0.5242 (+0.81%)
Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar

NEW YORK , Sept. 8, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) ("Klotho" or "the Company"), a biotechnology company advancing Klotho-based therapeutics for neurodegenerative...

KLTO : 0.5242 (+0.81%)

Business Summary

Klotho Neurosciences Inc. is a pharmaceutical company. It specializes in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system which are seen as key developments in treating neurodegenerative and age-related disorders. Klotho Neurosciences Inc.,...

See More

Key Turning Points

3rd Resistance Point 0.6218
2nd Resistance Point 0.5772
1st Resistance Point 0.5507
Last Price 0.5242
1st Support Level 0.4796
2nd Support Level 0.4350
3rd Support Level 0.4085

See More

52-Week High 3.9099
Fibonacci 61.8% 2.4597
Fibonacci 50% 2.0117
Fibonacci 38.2% 1.5637
Last Price 0.5242
52-Week Low 0.1135

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar